Therefore, the aim of the present study was to evaluate the pattern of the adaptive immune response in patients with stable severe psoriasis without treatment and patients undergoing systemic therapy with methotrexate or anti-TNF agents at different intervals of the therapeutic cycle. This evidence concerns the gene TNF and psoriasis.